STOKE THERAPEUTICS INC shareholders Q3 2023

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.

STOKE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 239,300$942,8420.00%
GILDER GAGNON HOWE & CO LLC 62,259$245,3000.00%
ALGERT GLOBAL LLC 16,550$650.00%
Woodline Partners LP 56,904$224,2020.00%
PROVENCE WEALTH MANAGEMENT GROUP 470$1,8520.00%
Mirae Asset Global Investments Co., Ltd. 146,076$575,5400.00%
BOOTHBAY FUND MANAGEMENT, LLC 10,000$39,4000.00%
Verition Fund Management LLC 15,255$60,1050.00%
Walleye Capital LLC 67,351$265,3630.00%
D. E. Shaw & Co., Inc. 205,166$808,3540.00%
ALPS ADVISORS INC 32,647$128,6290.00%
VIRGINIA RETIREMENT SYSTEMS ET AL 14,900$58,7060.00%
China Universal Asset Management Co., Ltd. 1,132$40.00%
TUDOR INVESTMENT CORP ET AL 18,252$71,9130.00%
STATE OF WISCONSIN INVESTMENT BOARD 79,524$313,3250.00%
SG Americas Securities, LLC 13,557$530.00%
MORGAN STANLEY 2,913,784$11,480,3090.00%
LOS ANGELES CAPITAL MANAGEMENT LLC 47,747$188,1230.00%
Man Group plc 113,540$447,3480.00%
MILLENNIUM MANAGEMENT LLC 275,339$1,084,8360.00%
External links

This page lists STOKE THERAPEUTICS INC's shareholders in Q3 2023. To view STOKE THERAPEUTICS INC's shareholder history, click here.